According to Santen Pharmaceutical 's latest financial reports the company's current earnings (TTM) are $26.44 M. In 2021 the company made an earning of $0.10 B a decrease over its 2020 earnings that were of $0.30 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | $26.44 M | -75.92% |
2021 | $0.10 B | -64.56% |
2020 | $0.30 B | -17.42% |
2019 | $0.37 B | -4.37% |
2018 | $0.39 B | 22.65% |
2017 | $0.31 B | -1.11% |
2016 | $0.32 B | -54.99% |
2015 | $0.71 B | 184.87% |
2014 | $0.25 B | -10.44% |
2013 | $0.28 B | -11.62% |
2012 | $0.31 B | -19.83% |
2011 | $0.39 B | 29.29% |
2010 | $0.30 B | 1.35% |
2009 | $0.30 B |